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Abstract: Inadequate immunologic, metabolic and cardiovascular homeostasis has been related to
either an alteration of the gut microbiota or to vitamin D deficiency. We analyzed whether vitamin
D deficiency alters rat gut microbiota. Male Wistar rats were fed a standard or a vitamin D-free
diet for seven weeks. The microbiome composition was determined in fecal samples by 16S rRNA
gene sequencing. The vitamin D-free diet produced mild changes on α- diversity but no effect on
β-diversity in the global microbiome. Markers of gut dysbiosis like Firmicutes-to-Bacteroidetes ratio or
the short chain fatty acid producing bacterial genera were not significantly affected by vitamin D
deficiency. Notably, there was an increase in the relative abundance of the Enterobacteriaceae, with
significant rises in its associated genera Escherichia, Candidatus blochmannia and Enterobacter in vitamin
D deficient rats. Prevotella and Actinomyces were also increased and Odoribacteraceae and its genus
Butyricimonas were decreased in rats with vitamin D-free diet. In conclusion, vitamin D deficit does
not induce gut dysbiosis but produces some specific changes in bacterial taxa, which may play a
pathophysiological role in the immunologic dysregulation associated with this hypovitaminosis.
Keywords: microbiota; 16S rRNA sequencing; vitamin D deficit
1. Introduction
The gut microbiota is an ecological community constituted by a large number of bacteria, archaea,
protists, fungi and viruses. The microbiota produces multiple metabolites that may cross the intestinal
barrier and exert biological effects [1]. The microbiota also impacts on the integrity of the gut barrier.
Gut barrier dysfunction may result in bacterial translocation from the intestines with increased plasma
lipopolysaccharides (LPS) [2]. Multiple studies have found a relationship between the microbiota and
adequate metabolic, hormonal and immunologic homeostasis [3–5]. Gut dysbiosis, i.e., an altered
composition of the intestinal microbiota in disease is associated with poor health outcomes. Dysbiosis
may be treated with probiotics, i.e., live strains of selected bacteria, or prebiotics, food components that
modulate the microbiota [6,7]. Multiple metabolic, cardiovascular, and respiratory diseases including
type 2 diabetes mellitus, obesity, systemic and pulmonary hypertension, atherosclerosis, heart failure
and chronic respiratory diseases have been linked to impaired gut microbiota [8–13]. Dysbiosis is
Nutrients 2019, 11, 2564; doi:10.3390/nu11112564 www.mdpi.com/journal/nutrients
Nutrients 2019, 11, 2564 2 of 11
frequently characterized by: (a) lower microbial diversity and richness, (b) changes in the relative
abundance of phyla with an increased Firmicutes to Bacteroidetes ratio (F/B), and (c) changes in short
chain fatty acids (SCFA) producing bacteria with a relative increase in lactate-producing bacteria and a
relative decrease in acetate- and butyrate-producing bacteria [2,4,14,15].
Vitamin D is produced from dermal exposure to sunlight or from the diet and is converted in the
liver into 25-OH-cholecaciferol or calcifediol (25OHVitD), whose measure serves as an indicator of the
vitamin D status. This is further metabolized mainly in the kidney into 1-α,25-dihydroxycholecalciferol,
the most active form, also named calcitriol, which activates the vitamin D receptor (VDR). Vitamin
D deficiency, which causes rickets and osteomalacia, is very common worldwide due to insufficient
solar light exposure and/or a reduced dietary intake [16]. Besides this well-known regulatory role
in the calcium-phosphorus and bone homeostasis, vitamin D is also involved in the control of other
physiological processes, such as cellular growth, intracellular metabolism and innate and adaptive
immunity. Vitamin D deficiency has also been related to infection, cancer and respiratory and
cardiovascular diseases [17–21]. Immune cells and peripheral tissues can also synthetize calcitriol
and express VDR. Thus, vitamin D has been proposed to have immunomodulatory properties and
insufficient vitamin D levels may lead to dysregulation of immune responses [22]. Moreover, vitamin
D is able to induce the expression of antibacterial proteins and exert antibiotic effects in a variety of cell
types [23].
We hypothesized that a deficiency in vitamin D induces changes in the gut microbiota.
2. Materials and Methods
The procedures involving animals were carried out according to the Spanish Royal Decree
1201/2005 and 53/2013 on the Care and Use of Laboratory Animals and approved by the institutional
Ethical Committees of the Universidad Complutense de Madrid (Madrid, Spain) and the regional
Committee for Laboratory Animals Welfare (Comunidad de Madrid, Ref. number PROEX-301/16).
2.1. Model of Vitamin D Deficiency
Twenty male Wistar rats of 180 g body weight (BW) from Envigo (Barcelona, Spain) were
maintained in the general animal facility of Universidad Complutense. Animals were randomly
allocated into two groups; rats fed with a standard diet (n = 10), which contained 1500 IU/kg
cholecalciferol (Teklad Global 18% Protein Rodent Diet, Envigo) and rats fed a vitamin D-free diet
(n = 10) (VitD-free, Teklad Custom Diet TD.120008, Envigo, n = 10) for seven weeks. Rats were housed,
two per box, with food and water ad libitum under standard conditions (22± 1 ◦C and 12:12 h dark/light
cycle). At week 7, animals were euthanized, plasma and feces were collected and the right and left
ventricle plus septum were weighed. Plasma 25OHVitD was measured using a chemiluminescence
immunoassay (ADVIA Centaur® Vitamin D Total assay, Siemens Healthcare Diagnostics) at the Clinical
Biochemistry Service, Gregorio Marañón Hospital.
2.2. DNA Extraction, 16S rRNA Gene Amplification, Bioinformatics
The gut microbiome was analyzed as previously reported [13]. Briefly, the feces were collected
at week 7 from each individual rat. We used G-spin columns (INTRON Biotechnology) to extract
DNA and treated the samples with proteinase K and RNAses. The V3–V4 region of the 16S rRNA
gene was amplified for 20–22 cycles from 3 ng of DNA [24]. PCR products (approx. 450 bp) included
extension tails, which allowed sample barcoding and the addition of specific Illumina sequences in a
second PCR for 10–12 cycles. Individual amplicon libraries were analyzed using a Bioanalyzer 2100
(Agilent) and a pool of samples was made in equimolar amounts. DNA samples were sequenced
at the Unidad de Genómica (Parque Científico de Madrid) on an Illumina MiSeq instrument with
2 × 300 paired-end read sequencing. DNA reads were quality filtered according to MiSeq standard
parameters (Illumina). We discarded all reads whose corrected brightest intensity in any of the first 25
sequencing cycles was less than 60% of the sum of brightest intensity and the next brightest. We find
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that this criterion provides reasonable discrimination between good and bad data [25]. Depending
on the loading density, we typically kept between 50% and 70% of the raw reads. The final output
was around 150 K reads on average per rat (range: 90–220 K). Operational taxonomic units (OTUs)
were assigned using the 16S-metagenomics workflow (1.0.1) associated with the Base Space Hub
(Illumina, 2013 version [26]). An Illumina-curated version of the GreenGenes taxonomic database,
which implements the Ribosomal Database Project (RDP) Classifier was used to classify the OTUs [27].
The rarefaction curves (Supplementary Materials, Figure S1) show that the main OTUs are effectively
detected. The Taxonomy Database (National Center for Biotechnology Information) was used for
classification and nomenclature. Bacteria were classified based on the SCFA end product as previously
described [28,29] (Supplementary Materials, Table S1).
2.3. Statistical Analysis
Reads in each operational taxonomic unit (OTU) were normalized to total reads in each sample.
Only taxa with a percentage of reads >0.001% were used for the analysis. The Shannon, Chao1,
Simpsons and Pielou indices were calculated to analyze α-diversity using Past software (ver3.21, Oslo,
Norway) [30]. Principal components analysis (PCA) [31] was also carried out with Past software [32].
Statistical taxonomic comparisons were performed using the linear discriminant analysis (LDA) effect
size (LEfSe) using the Galaxy Hutlab online platform [33,34], considering alpha values of 0.05 for the
factorial Kruskal-Wallis test among classes and for the pairwise Wilcoxon test between subclasses.
Values > 2 or < −2 for the logarithmic LDA score were considered significant [35]. The Galaxy Hutlab
web was also used to plot the cladogram. All other analysis and plots were carried out using Prism
software (Prism version 7.04 for Windows, GraphPad Software, La Jolla California USA [36]). Normally
distributed variables were compared using a two-tailed unpaired t test, otherwise data was analyzed
using the Mann Whitney test.
3. Results
3.1. Model of Vitamin D Deficit
The exposure to a vitamin D-free diet for 7 weeks induced a marked decrease in 25OHVitD
plasma values from 22.2 ± 1.4 to 7.7 ± 1.0 ng/mL (Figure 1A). There was no change in body weight
and a modest increase in the weight of the left ventricle plus septum but not in the right ventricle
(Figure 1B,C).
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Figure 1. Vitamin D status, and body and heart weight. (A) Plasma 25OHVitD. (B) Body weight and 
(C) right ventricular (RV) and left ventricular + septum (LV + S) weights. Results are mean  ±  s.e.m. 
for the standard diet (SD, n = 10) and vitamin D-free diet group (n = 10). Results were compared by 
student’s t-test * p < 0.05 and ** p < 0.01 vs. SD. 
3.2. Bacterial α- and β-Diversity 
Between 250 and 450 species were identified in each sample. The number of species identified 
was similar in the rats under the standard diet and those with vitamin D-free diet (Figure 2A). The 
parameters indicating α-diversity such as the Pielou, Shannon and Simpson indices were 
significantly increased in vitamin D-free diet group but the Chao1 index was not significantly affected 
(Figure 2).  
Figure 1. Vitamin D status, and body and heart weight. (A) Plasma 25OHVitD. (B) Body weight and
(C) right ventricular (RV) and left ventricular + septum (LV + S) weights. Results are mean ± s.e. .
for the standard diet (SD, n = 10) and vitamin D-fre diet group (n = 10). Results were compared by
student’s t-test * p < 0.05 and ** p < . s. .
3.2. Bacterial α- and β-Diversity
Between 250 and 450 species were identified in each sample. The number of species identified was
similar in the rats under the standard diet and those with vitamin D-free diet (Figure 2A). The parameters
Nutrients 2019, 11, 2564 4 of 11
indicating α-diversity such as the Pielou, Shannon and Simpson indices were significantly increased in
vitamin D-free diet group but the Chao1 index was not significantly affected (Figure 2).
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Figure 3. Effects of vitamin D-free diet on bacterial β-diversity. β-diversity was analyzed using the 
principal coordinate analysis (PCA) of the standard diet group using PAST3.0. The principal 
components PC1 and PC2 are plotted in a bidimensional figure. The white spheres represent rats fed 
a standard diet (SD, n = 10) and black spheres rats fed a vitamin D-free diet (n = 10). 
Figure 2. Effects of vitamin D-free diet on ecological parameters of the bacterial communities. Fecal
samples were collected from standard diet (SD, n = 10) and vitamin D-free diet group (n = 10) rats.
The microbial alpha diversity was analyzed using (A) numbers of species, (B) Chao richness, (C) Pielou,
(D) Shannon and (E) Simpsons indices. Results are expressed as a scatterplot and means and were
compared by a student’s t-test; * p < 0.05 vs. SD.
A bidimensional principal component analysis (PCA) of the microbiome was performed in an
unsupervised manner, which measures the diversity of microorganisms among samples, i.e.,β-diversity.
This analysis showed no clear clustering of the animals into the control and vitamin D-free diet groups
(Figure 3).
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Figure 3. Effects of vitamin D-free diet on bacterial β-diversity. β-diversity was analyzed using
the principal coordinate analysis (PCA) of the standard diet group using PAST3.0. The principal
compon nts PC1 and PC2 are plott d in a bidimens onal figu e. The white sphere represent rats fed a
standard diet (SD, = 10) nd black spheres rats fed a vitamin D-free diet (n = 10).
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3.3. Taxa Composition
We performed an LDA effect size (LEfSe) analysis for the whole bacterial taxa identified in
the feces to support high-dimensional class comparisons. The results of this analysis are shown in
Supplementary Materials, Figure S2. Forty-one taxa were significantly increased in rats exposed to a
VitD-free diet and five taxa were decreased. A cladogram summarizing the phylogenetic relationship
between these changes is shown in Supplementary Materials, Figure S3.
Firmicutes was the most abundant phylum in the rat feces, followed by Verrucomicrobia, Bacteroidetes,
Proteobacteria, Actinobacteria and Tenericutes, in both groups (Figure 4A). Among these most abundant
phyla there was no significant differences in their relative abundance when comparing animals with the
standard diet and those with the vitamin D-free diet. We found a large variability in the Verrucomicrobia
and to a lesser extent in the Bacteroidetes phylum. The ratio of Firmicutes to Bacteroidetes (F/B), which is
a widely used measure of bacterial dysbiosis was highly variable (Figure 4B). There was an apparent
trend for an increased F/B ratio in the Vit D-free group, the median increased from 9.3 to 19.7, but the
difference was not statistically significant (p > 0.05, Mann Whitney test). Among the less abundant
phyla, there was a highly significant increase in Synergistetes (Figure 4A).
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Figure 4. Effects of the vitamin D-free diet on the relative phylum abundance. The most abundant
phyla for the standard diet (SD, n = 10) and vitamin D-free diet group (n = 10) were expressed as a
percent of total reads and represented in (A) as a box and whiskers plot, *** p < 0.001 vs. SD, student’s
t-test. (B) Firmicutes to Bacteroidetes ratio (F/B ratio), as a biomarker of gut dysbiosis, is represented as
a scatterplot and median.
The significant changes induced by vitamin D-free diet in bacterial families and genera are shown
in Figures 5 and 6A, respectively. Notably, there was an increase in the Enterobacteriaceae family with
significant rises in its associated genera Escherichia, Candidatus blochmannia and Enterobacter, an increase
in Prevotellaceae and its genus Prevotella and a decrease in the family Odoribacteraceae and its genus
Butyricimonas in rats with vitamin D-free diet.
3.4. SCFA-Producing Bacteria
We analyzed the changes in the relative abundance of SCFA-producing bacteria as an additional
measure of gut dysbiosis (Figure 6B). Some specific acetate-producing genera such as Blautia, Lachnospira,
Actinomyces and Prevotella were increased by vitamin D-free diet as mentioned above. Similarly, some
butyrate-producing genera such as Faecalibacterium and Roseburia were relatively more abundant in
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rats with VitD-free diet. However, we found no significant changes in the sum of all bacterial reads for
acetate-, butyrate-, lactate- or propionate-producing bacteria.Nutrients 2019, 11, x FOR PEER REVIEW 6 of 11 
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4. Discussion
The role of gut dysbiosis in the pathogenesis of many diseases, including diabetes mellitus,
obesity, cancer, and psychiatric, respiratory and cardiovascular disorders is rapidly emerging. Similarly,
vitamin D deficiency, which is the most common nutritional deficiency, has been related to a number of
metabolic, cardiovascular, respiratory and psychiatric disorders. The primary end point of the present
study was to analyze whether vitamin D deficiency induces gut dysbiosis. This might help to explain
some of the health-related disorders associated with this hypovitaminosis.
Determination of 25OHVitD plasma levels are the most reliable indicator of vitamin D storage.
Values below 20 ng/mL are usually considered deficient [37,38] and are associated with secondary
hyperparathyroidism, muscle weakness, osteomalacia or osteoporosis. We fed the rats for seven weeks
with a VitD-free diet, leading to a severe vitamin D deficiency (mean plasma 25OHVitD <10 ng/mL).
Animal studies of the microbiota, like the present one, can be performed in strictly controlled conditions
of diet and environment. However, extrapolation of rodent models to human beings should be done
with caution. For the first time we report vitamin D-free diet-induced changes in the microbiota in the
rat, which is more representative of the human gut microbiota than mice [39]. For obvious reasons,
a randomized controlled study inducing vitamin D deficiency in humans cannot be performed. To our
knowledge, only a small controlled human study in patients with cystic fibrosis [40] has been carried
out to study the opposite approach, i.e., to analyze the impact on the microbiota of restoring vitamin
D levels in patients with vitamin D deficiency. The cutoff value of 25OHVitD used in this study to
classify patients as deficient was 30 ng/mL and the post intervention mean values in the placebo arm
was ≈ 25 ng/mL, which is often considered within the normal range, compared to the active VitD arm
≈ 46 ng/mL. Several non-controlled or observational human studies and some studies in mice have
also been published [41].
Our results show that a VitD-free diet did not produce large changes in the gut microbiota
characteristics of dysbiosis, i.e., it did not lower microbial α-diversity and richness, it did not increase
the Firmicutes to Bacteroidetes ratio, and it did not change the relative abundance of SCFA-producing
bacteria. Moreover, principal component analysis of the bacterial community could not discriminate
VitD-free diet treated from control animals in an unsupervised manner. α-diversity represents both the
richness and evenness of species bacterial diversity within each sample and it is usually analyzed using
the Chao1, Pielou, Shannon and/or Simpsons indices and the number of species. They are commonly
used as indirect indicators of a healthy bacterial community and associated with a better health status.
However, paradoxically, these indices, with the exception of the Chao1 index, were modestly but
significantly increased by the vitamin D-free diet. This reduced diversity may be associated with the
antibacterial effects of vitamin D [23]. A similar trend was observed both in mice with colitis and in
healthy mice exposed to a vitamin D-free diet compared to a standard diet [42]. Other studies analyzing
the association between vitamin D and alpha diversity in human studies were not consistent [41].
Despite the lack of effect on theα- andβ-diversity, vitamin D-free diet produced significant changes
in the relative abundance of forty-nine taxa, with fourty-four increased and five decreased. The present
study does not establish a causal relationship between the specific bacterial changes described herein
and the potential health deleterious effect of vitamin D deficiency or the putative mechanisms involved.
However, these changes resemble those found in other pathological conditions. Notably, with vitamin
D-free diet we found significant rises in typical members of the oral and gut microbiota, which are
often responsible for enteral, urinary and respiratory tract infections, such as Enterobacteriaceae and its
genera Escherichia and Enterobacter. These genera belong to the class Gammaproteobacteria, which was
significantly more abundant in the stool samples of vitamin D-insufficient subjects compared with
vitamin D-sufficient subjects [42]. Other opportunistic bacteria, Prevotella and Actinomyces, commonly
found in multiple types of infection, were also increased in vitamin D deficient rats. These data
suggest that vitamin D deficiency increases the relative abundance of opportunistic pathogens which,
in the context of intestinal barrier dysfunction, may favour pathogen bacterial translocation and
systemic infection and inflammation. In fact, vitamin D preserves the intestinal epithelial barrier
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function [43]. Because the composition of the microbiota is essential for the intestinal barrier integrity,
we speculate that the changes in the microbiota described herein may also be responsible for the
vitamin D deficiency-induced alteration of the gut barrier. We also found a highly significant increase
in bacteria from the phylum Synergistetes, which are considered as opportunistic pathogens involved
in periodontitis [44], and its genus Dethiosulfovibrio, but its significance is unknown. Synergistetes and
Dethiosulfovibrionaceae have also been reported in a rat model of acute myocardial infarction [45].
The family Odoribacteraceae and its genera Odoribacter and Butyricimonas have been reported
to be depleted in several pathological conditions and animal models of disease such as overweight
and obese pregnant women with high blood pressure, in sedentary mice, liver injury and pulmonary
hypertension [13,46,47]. We found that this family and Butyricimonas, were decreased in vitamin D
deficient rats. Likewise, this family was increased in response to vitamin D supplementation in vitamin
D-insufficient subjects with cystic fibrosis [40]. Interestingly, Odoribacter was also depleted in vitamin
D receptor knockout mice suggesting that this change is a VDR-mediated effect [48]. The potential
protective effect of these genera is unclear. However, the abundance of Butyricimonas, which was
decreased after high fat diet and reversed by statins or fecal transplantation, was correlated with the
inflammatory cytokines IL-1β and TGFβ1 in the ileum, suggesting an anti-inflammatory effect [49].
5. Conclusions
In conclusion, vitamin D deficiency does not induce gut dysbiosis in the rat but produced specific
changes in bacterial taxa, which may play a pathophysiological role in the immunologic dysregulation
associated with this hypovitaminosis.
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